198 related articles for article (PubMed ID: 32590884)
1. Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6-NTRK3 fusion, and the rare KLHL7-BRAF fusion.
Zhao M; Yin M; Kuick CH; Chen H; Aw SJ; Merchant K; Ng EHQ; Gunaratne S; Loh AHP; Gu W; Tang H; Chang KTE
Histopathology; 2020 Oct; 77(4):611-621. PubMed ID: 32590884
[TBL] [Abstract][Full Text] [Related]
2. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.
Rubin BP; Chen CJ; Morgan TW; Xiao S; Grier HE; Kozakewich HP; Perez-Atayde AR; Fletcher JA
Am J Pathol; 1998 Nov; 153(5):1451-8. PubMed ID: 9811336
[TBL] [Abstract][Full Text] [Related]
3. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.
Knezevich SR; Garnett MJ; Pysher TJ; Beckwith JB; Grundy PE; Sorensen PH
Cancer Res; 1998 Nov; 58(22):5046-8. PubMed ID: 9823307
[TBL] [Abstract][Full Text] [Related]
4. Infantile fibrosarcoma with an EGFR kinase domain duplication: Underlining a close relationship with congenital mesoblastic nephroma and highlighting a similar morphological spectrum.
van Spronsen R; Kester LA; Knops RRG; van de Sande MAJ; van Leenders GJLH; de Laat PCJ; Stortelder E; Korpershoek E; van Noesel MM; Meister MT; Koerkamp MJAG; de Graaf N; Giovannoni I; Tops BBJ; de Krijger RR; Ter Horst SAJ; Flucke U; Alaggio R; Hiemcke-Jiwa LS
Ann Diagn Pathol; 2022 Apr; 57():151885. PubMed ID: 35032896
[TBL] [Abstract][Full Text] [Related]
5. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
[TBL] [Abstract][Full Text] [Related]
6. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors.
Argani P; Fritsch M; Kadkol SS; Schuster A; Beckwith JB; Perlman EJ
Mod Pathol; 2000 Jan; 13(1):29-36. PubMed ID: 10658907
[TBL] [Abstract][Full Text] [Related]
7. Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis.
Watanabe N; Kobayashi H; Hirama T; Kikuta A; Koizumi S; Tsuru T; Kaneko Y
Cancer Genet Cytogenet; 2002 Jul; 136(1):10-6. PubMed ID: 12165445
[TBL] [Abstract][Full Text] [Related]
8. An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma.
Misove A; Vicha A; Zapotocky M; Malis J; Balko J; Nemeckova T; Szabova J; Kyncl M; Novakova-Kodetova D; Stolova L; Jencova P; Broz P; Krskova L
Genes Chromosomes Cancer; 2021 Dec; 60(12):837-840. PubMed ID: 34378283
[TBL] [Abstract][Full Text] [Related]
9. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
Csanyi-Bastien M; Lanic MD; Beaussire L; Ferric S; François A; Meseure D; Jardin F; Wassef M; Ruminy P; Laé M
Am J Surg Pathol; 2021 Nov; 45(11):1487-1498. PubMed ID: 33899788
[TBL] [Abstract][Full Text] [Related]
10. Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement.
El Demellawy D; Cundiff CA; Nasr A; Ozolek JA; Elawabdeh N; Caltharp SA; Masoudian P; Sullivan KJ; de Nanassy J; Shehata BM
Pathology; 2016 Jan; 48(1):47-50. PubMed ID: 27020209
[TBL] [Abstract][Full Text] [Related]
11. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study.
Gadd S; Beezhold P; Jennings L; George D; Leuer K; Huang CC; Huff V; Tognon C; Sorensen PH; Triche T; Coffin CM; Perlman EJ
J Pathol; 2012 Sep; 228(1):119-30. PubMed ID: 22374738
[TBL] [Abstract][Full Text] [Related]
12. Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma.
Lei L; Stohr BA; Berry S; Lockwood CM; Davis JL; Rudzinski ER; Kunder CA
Pract Lab Med; 2020 Aug; 21():e00164. PubMed ID: 32490123
[TBL] [Abstract][Full Text] [Related]
13. Expression of ETV6-NTRK in classical, cellular and mixed subtypes of congenital mesoblastic nephroma.
Anderson J; Gibson S; Sebire NJ
Histopathology; 2006 May; 48(6):748-53. PubMed ID: 16681692
[TBL] [Abstract][Full Text] [Related]
14. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
Rudzinski ER; Lockwood CM; Stohr BA; Vargas SO; Sheridan R; Black JO; Rajaram V; Laetsch TW; Davis JL
Am J Surg Pathol; 2018 Jul; 42(7):927-935. PubMed ID: 29683818
[TBL] [Abstract][Full Text] [Related]
15. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
Yamamoto H; Nozaki Y; Sugii A; Taguchi K; Hongo T; Jiromaru R; Sato M; Nakano T; Hashimoto K; Fujiwara M; Oda Y
Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751
[TBL] [Abstract][Full Text] [Related]
16. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors.
Koo SC; Schieffer KM; Lee K; Gupta A; Pfau RB; Avenarius MR; Stonerock E; LaHaye S; Fitch J; Setty BA; Roberts R; Ranalli M; Conces MR; Bu F; Mardis ER; Cottrell CE
Genes Chromosomes Cancer; 2023 Jan; 62(1):17-26. PubMed ID: 35801295
[TBL] [Abstract][Full Text] [Related]
17. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors.
Motta M; Barresi S; Pizzi S; Bifano D; Lopez Marti J; Garrido-Pontnou M; Flex E; Bruselles A; Giovannoni I; Rotundo G; Fragale A; Tirelli V; Vallese S; Ciolfi A; Bisogno G; Alaggio R; Tartaglia M
J Pathol; 2024 Jun; 263(2):166-177. PubMed ID: 38629245
[TBL] [Abstract][Full Text] [Related]
18. Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma.
Halalsheh H; McCarville MB; Neel M; Reynolds M; Cox MC; Pappo AS
Pediatr Blood Cancer; 2018 Oct; 65(10):e27271. PubMed ID: 29893456
[TBL] [Abstract][Full Text] [Related]
19. ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study.
Vokuhl C; Nourkami-Tutdibi N; Furtwängler R; Gessler M; Graf N; Leuschner I
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286563
[TBL] [Abstract][Full Text] [Related]
20. Second Report of
Hughes CE; Correa H; Benedetti DJ; Smith B; Sumegi J; Bridge J
Pediatr Dev Pathol; 2021; 24(6):554-558. PubMed ID: 34120511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
